# Central and Cerebral Circulation in Early Stages After LVAD Implantation

> **NCT03087669** · NA · UNKNOWN · sponsor: **Sahlgrenska University Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Heart Failure, Left-Sided
- Heart Failure, Right-Sided

## Interventions

- **DEVICE:** LVAD flow velocity setting-Rounds per Minute(RPM) on HeartMate III®
- **DRUG:** MAP intervention using Noradrenalin

## Key facts

- **NCT ID:** NCT03087669
- **Lead sponsor:** Sahlgrenska University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-16
- **Primary completion:** 2020-03-01
- **Final completion:** 2020-03-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2017-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03087669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03087669, "Central and Cerebral Circulation in Early Stages After LVAD Implantation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03087669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*